1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Pre-renal 1.2.3 Intrinsic-renal 1.2.4 Post-renal 1.3 Market by Application 1.3.1 Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Public Hospital 1.3.3 Private Hospital 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global ICU-acquired Acute Kidney Treatment Market Perspective (2017-2028) 2.2 ICU-acquired Acute Kidney Treatment Growth Trends by Region 2.2.1 ICU-acquired Acute Kidney Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 ICU-acquired Acute Kidney Treatment Historic Market Size by Region (2017-2022) 2.2.3 ICU-acquired Acute Kidney Treatment Forecasted Market Size by Region (2023-2028) 2.3 ICU-acquired Acute Kidney Treatment Market Dynamics 2.3.1 ICU-acquired Acute Kidney Treatment Industry Trends 2.3.2 ICU-acquired Acute Kidney Treatment Market Drivers 2.3.3 ICU-acquired Acute Kidney Treatment Market Challenges 2.3.4 ICU-acquired Acute Kidney Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue 3.1.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue (2017-2022) 3.1.2 Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Players (2017-2022) 3.2 Global ICU-acquired Acute Kidney Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by ICU-acquired Acute Kidney Treatment Revenue 3.4 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio 3.4.1 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by ICU-acquired Acute Kidney Treatment Revenue in 2021 3.5 ICU-acquired Acute Kidney Treatment Key Players Head office and Area Served 3.6 Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service 3.7 Date of Enter into ICU-acquired Acute Kidney Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 ICU-acquired Acute Kidney Treatment Breakdown Data by Type 4.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Type (2017-2022) 4.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2023-2028) 5 ICU-acquired Acute Kidney Treatment Breakdown Data by Application 5.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Application (2017-2022) 5.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America ICU-acquired Acute Kidney Treatment Market Size (2017-2028) 6.2 North America ICU-acquired Acute Kidney Treatment Market Size by Type 6.2.1 North America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) 6.2.2 North America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) 6.2.3 North America ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028) 6.3 North America ICU-acquired Acute Kidney Treatment Market Size by Application 6.3.1 North America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) 6.3.2 North America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) 6.3.3 North America ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028) 6.4 North America ICU-acquired Acute Kidney Treatment Market Size by Country 6.4.1 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) 6.4.2 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe ICU-acquired Acute Kidney Treatment Market Size (2017-2028) 7.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Type 7.2.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) 7.2.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) 7.2.3 Europe ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028) 7.3 Europe ICU-acquired Acute Kidney Treatment Market Size by Application 7.3.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) 7.3.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) 7.3.3 Europe ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028) 7.4 Europe ICU-acquired Acute Kidney Treatment Market Size by Country 7.4.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) 7.4.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size (2017-2028) 8.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type 8.2.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application 8.3.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region 8.4.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America ICU-acquired Acute Kidney Treatment Market Size (2017-2028) 9.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type 9.2.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) 9.2.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) 9.2.3 Latin America ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028) 9.3 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application 9.3.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) 9.3.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) 9.3.3 Latin America ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028) 9.4 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country 9.4.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) 9.4.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size (2017-2028) 10.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type 10.2.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application 10.3.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country 10.4.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Quark Pharmaceuticals 11.1.1 Quark Pharmaceuticals Company Details 11.1.2 Quark Pharmaceuticals Business Overview 11.1.3 Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Introduction 11.1.4 Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.1.5 Quark Pharmaceuticals Recent Developments 11.2 Fresenius Medical Care 11.2.1 Fresenius Medical Care Company Details 11.2.2 Fresenius Medical Care Business Overview 11.2.3 Fresenius Medical Care ICU-acquired Acute Kidney Treatment Introduction 11.2.4 Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.2.5 Fresenius Medical Care Recent Developments 11.3 B. Braun 11.3.1 B. Braun Company Details 11.3.2 B. Braun Business Overview 11.3.3 B. Braun ICU-acquired Acute Kidney Treatment Introduction 11.3.4 B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.3.5 B. Braun Recent Developments 11.4 Baxter international 11.4.1 Baxter international Company Details 11.4.2 Baxter international Business Overview 11.4.3 Baxter international ICU-acquired Acute Kidney Treatment Introduction 11.4.4 Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.4.5 Baxter international Recent Developments 11.5 Angion Biomedica Corp 11.5.1 Angion Biomedica Corp Company Details 11.5.2 Angion Biomedica Corp Business Overview 11.5.3 Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Introduction 11.5.4 Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.5.5 Angion Biomedica Corp Recent Developments 11.6 Asahi Kasei Medical 11.6.1 Asahi Kasei Medical Company Details 11.6.2 Asahi Kasei Medical Business Overview 11.6.3 Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Introduction 11.6.4 Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.6.5 Asahi Kasei Medical Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Pre-renal Table 3. Key Players of Intrinsic-renal Table 4. Key Players of Post-renal Table 5. Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global ICU-acquired Acute Kidney Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global ICU-acquired Acute Kidney Treatment Market Size by Region (2017-2022) & (US$ Million) Table 8. Global ICU-acquired Acute Kidney Treatment Market Share by Region (2017-2022) Table 9. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global ICU-acquired Acute Kidney Treatment Market Share by Region (2023-2028) Table 11. ICU-acquired Acute Kidney Treatment Market Trends Table 12. ICU-acquired Acute Kidney Treatment Market Drivers Table 13. ICU-acquired Acute Kidney Treatment Market Challenges Table 14. ICU-acquired Acute Kidney Treatment Market Restraints Table 15. Global ICU-acquired Acute Kidney Treatment Revenue by Players (2017-2022) & (US$ Million) Table 16. Global ICU-acquired Acute Kidney Treatment Revenue Share by Players (2017-2022) Table 17. Global Top ICU-acquired Acute Kidney Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2021) Table 18. Ranking of Global Top ICU-acquired Acute Kidney Treatment Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by ICU-acquired Acute Kidney Treatment Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service Table 22. Date of Enter into ICU-acquired Acute Kidney Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 25. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2017-2022) Table 26. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2023-2028) Table 28. Global ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 29. Global ICU-acquired Acute Kidney Treatment Revenue Share by Application (2017-2022) Table 30. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global ICU-acquired Acute Kidney Treatment Revenue Share by Application (2023-2028) Table 32. North America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 33. North America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million) Table 34. North America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 35. North America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million) Table 36. North America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million) Table 37. North America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million) Table 62. Quark Pharmaceuticals Company Details Table 63. Quark Pharmaceuticals Business Overview Table 64. Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Product Table 65. Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 66. Quark Pharmaceuticals Recent Developments Table 67. Fresenius Medical Care Company Details Table 68. Fresenius Medical Care Business Overview Table 69. Fresenius Medical Care ICU-acquired Acute Kidney Treatment Product Table 70. Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 71. Fresenius Medical Care Recent Developments Table 72. B. Braun Company Details Table 73. B. Braun Business Overview Table 74. B. Braun ICU-acquired Acute Kidney Treatment Product Table 75. B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 76. B. Braun Recent Developments Table 77. Baxter international Company Details Table 78. Baxter international Business Overview Table 79. Baxter international ICU-acquired Acute Kidney Treatment Product Table 80. Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 81. Baxter international Recent Developments Table 82. Angion Biomedica Corp Company Details Table 83. Angion Biomedica Corp Business Overview Table 84. Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Product Table 85. Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 86. Angion Biomedica Corp Recent Developments Table 87. Asahi Kasei Medical Company Details Table 88. Asahi Kasei Medical Business Overview Table 89. Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Product Table 90. Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 91. Asahi Kasei Medical Recent Developments Table 92. Research Programs/Design for This Report Table 93. Key Data Information from Secondary Sources Table 94. Key Data Information from Primary Sources List of Figures Figure 1. Global ICU-acquired Acute Kidney Treatment Market Share by Type: 2021 VS 2028 Figure 2. Pre-renal Features Figure 3. Intrinsic-renal Features Figure 4. Post-renal Features Figure 5. Global ICU-acquired Acute Kidney Treatment Market Share by Application: 2021 VS 2028 Figure 6. Public Hospital Case Studies Figure 7. Private Hospital Case Studies Figure 8. ICU-acquired Acute Kidney Treatment Report Years Considered Figure 9. Global ICU-acquired Acute Kidney Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global ICU-acquired Acute Kidney Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global ICU-acquired Acute Kidney Treatment Market Share by Region: 2021 VS 2028 Figure 12. Global ICU-acquired Acute Kidney Treatment Market Share by Players in 2021 Figure 13. Global Top ICU-acquired Acute Kidney Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2021) Figure 14. The Top 10 and 5 Players Market Share by ICU-acquired Acute Kidney Treatment Revenue in 2021 Figure 15. North America ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 16. North America ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028) Figure 17. North America ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028) Figure 18. North America ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028) Figure 19. United States ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 22. Europe ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028) Figure 23. Europe ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028) Figure 24. Europe ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028) Figure 25. Germany ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 32. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028) Figure 33. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028) Figure 34. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size Share by Region (2017-2028) Figure 35. China ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Japan ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. South Korea ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Southeast Asia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. India ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Australia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 41. Latin America ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 42. Latin America ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028) Figure 43. Latin America ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028) Figure 44. Latin America ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028) Figure 45. Mexico ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Brazil ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 48. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028) Figure 49. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028) Figure 50. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028) Figure 51. Turkey ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Saudi Arabia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. UAE ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Quark Pharmaceuticals Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 55. Fresenius Medical Care Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 56. B. Braun Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 57. Baxter international Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 58. Angion Biomedica Corp Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 59. Asahi Kasei Medical Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Quark Pharmaceuticals Fresenius Medical Care B. Braun Baxter international Angion Biomedica Corp Asahi Kasei Medical